Clinical Trial Update: RALOX as Second Line Treatment for Advanced Malignant Biliary System Tumor [Phase 2]

View source ↗

Summary

Phase II trial update for RALOX as second-line treatment in advanced malignant biliary system tumors, status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangioadenoma
• Cholangiocarcinoma

Drugs mentioned

• RALOX

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Cholangioadenoma | Phase 2 | Status: UNKNOWN